Management indicated that the launch of Leqselvi could be delayed until December 2026 if the company does not secure a favourable judgment in the ongoing patent infringement case.
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Unpatched vulnerabilities in Contec CMS8000 patient monitors expose devices to remote access, file overwrites, and data leaks.
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.
US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...